Abstract
Genome-wide association study (GWAS) has become a commonly adopted approach for revealing the genetic architecture of complex diseases, with respect to uncovering the unknown genetic variants involved in the disease, their variations in the population and the magnitude of their effects. Though a substantial number of disease-susceptibility variants have been identified, the genetic architecture of complex diseases has remained elusive. It is unclear how many genetic variants in the human genome are associated with diseases, and how the genetic variants interact with one another to cause diseases. This challenge is partly due to the pervasive gene-gene interactions that underlie complex human diseases. Whereas a number of statistical methods have been developed for detecting gene-gene interactions, they are designed for various purposes, such as a particular study design, the order of the interactions being examined, and the measurement of disease phenotypes. This paper provides a survey of the currently available statistical methods and patents from the perspective of their application to various types of phenotypic traits. We also discuss the strength of each method as well as the biological interpretation of results.
Keywords: Epistasis, statistical methods, genetic association study, phenotypic traits
Recent Patents on Biotechnology
Title:On Epistasis: A Methodological Review for Detecting Gene-Gene Interactions Underlying Various Types of Phenotypic Traits
Volume: 6 Issue: 3
Author(s): Ming Li, Xiang-Yang Lou and Qing Lu
Affiliation:
Keywords: Epistasis, statistical methods, genetic association study, phenotypic traits
Abstract: Genome-wide association study (GWAS) has become a commonly adopted approach for revealing the genetic architecture of complex diseases, with respect to uncovering the unknown genetic variants involved in the disease, their variations in the population and the magnitude of their effects. Though a substantial number of disease-susceptibility variants have been identified, the genetic architecture of complex diseases has remained elusive. It is unclear how many genetic variants in the human genome are associated with diseases, and how the genetic variants interact with one another to cause diseases. This challenge is partly due to the pervasive gene-gene interactions that underlie complex human diseases. Whereas a number of statistical methods have been developed for detecting gene-gene interactions, they are designed for various purposes, such as a particular study design, the order of the interactions being examined, and the measurement of disease phenotypes. This paper provides a survey of the currently available statistical methods and patents from the perspective of their application to various types of phenotypic traits. We also discuss the strength of each method as well as the biological interpretation of results.
Export Options
About this article
Cite this article as:
Li Ming, Lou Xiang-Yang and Lu Qing, On Epistasis: A Methodological Review for Detecting Gene-Gene Interactions Underlying Various Types of Phenotypic Traits, Recent Patents on Biotechnology 2012; 6 (3) . https://dx.doi.org/10.2174/1872208311206030230
DOI https://dx.doi.org/10.2174/1872208311206030230 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Vascular Toxicity of Chemotherapeutic Agents
Current Vascular Pharmacology Cigarette Smoking is Associated with Decreased Bone Gla-protein (BGP) Levels in Hemodialysis Patients
Current Vascular Pharmacology Role of Inflammation in Diabetic Nephropathy
Current Diabetes Reviews Epidemiology of Septic Acute Kidney Injury
Current Drug Targets Inhibitory Role of Resveratrol in the Development of Profibrogenesis and Fibrosis Mechanisms
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Formaldehyde as a trigger for protein aggregation and potential target for mitigation of age-related, progressive cognitive impairment
Current Topics in Medicinal Chemistry Stem Cell Based Tissue Engineering and Regenerative Medicine: A Review Focusing on Adult Stem Cells
Current Tissue Engineering (Discontinued) Vitamin D Insufficiency and Diabetes Risks
Current Drug Targets The Forward Path for Biopharmaceuticals and Biosimilars: Emerging Options in the Selection of Host Cell Systems
Current Biotechnology Sodium-glucose Cotransporter 2 Inhibitors and Ischemic Stroke
Cardiovascular & Hematological Disorders-Drug Targets Bone Marrow Microenvironment: A Newly Recognized Target for Diabetes- Induced Cellular Damage
Endocrine, Metabolic & Immune Disorders - Drug Targets Inhibitors of Protein Tyrosine Phosphatase 1B (PTP1B)
Current Topics in Medicinal Chemistry Epitope Identification and Discovery Using Phage Display Libraries: Applications in Vaccine Development and Diagnostics
Current Drug Targets Major Depressive Disorder and Diabetes: Does Serotonin Bridge the Gap?
Current Diabetes Reviews Oxidative Stress, HDL and Atherosclerosis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Management of Hyperglycemia in Gestational Diabetes Mellitus
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) New Hybrid Scaffolds based on Hydrazinyl Thiazole Substituted Coumarin; As Novel Leads of Dual Potential; In Vitro α-Amylase Inhibitory and Antioxidant (DPPH and ABTS Radical Scavenging) Activities
Medicinal Chemistry Vascular Cognitive Disorder: A Diagnostic and Pharmacological Treatment Updating
Current Psychopharmacology Forkhead Transcription Factors: Formulating a FOXO Target for Cognitive Loss
Current Neurovascular Research Serum Testosterone and Cognitive Function in Ageing Male: Updating the Evidence
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)